Asset Details
Do you wish to reserve the book?
Pathogenic mutations in neurofibromin identifies a leucine-rich domain regulating glioma cell invasiveness
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Pathogenic mutations in neurofibromin identifies a leucine-rich domain regulating glioma cell invasiveness
Do you wish to request the book?
Pathogenic mutations in neurofibromin identifies a leucine-rich domain regulating glioma cell invasiveness
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Pathogenic mutations in neurofibromin identifies a leucine-rich domain regulating glioma cell invasiveness
2019
Overview
Glioblastoma (GBM) is the most aggressive tumor of the brain.
NF1
, a tumor suppressor gene and RAS-GTPase, is one of the highly mutated genes in GBM. Dysregulated
NF1
expression promotes cell invasion, proliferation, and tumorigenesis. Loss of
NF1
expression in glioblastoma is associated with increased aggressiveness of the tumor. Here, we show that
NF1
-loss in patient-derived glioma cells using shRNA increases self-renewal, heightens cell invasion, and promotes mesenchymal subtype and epithelial mesenchymal transition-specific gene expression that enhances tumorigenesis. The neurofibromin protein contains at least four major domains, with the GAP-related domain being the most well-studied. In this study, we report that the leucine-rich domain (LRD) of neurofibromin inhibits invasion of human glioblastoma cells without affecting their proliferation. Moreover, under conditions tested, the NF1-LRD fails to hydrolyze Ras-GTP to Ras-GDP, suggesting that its suppressive function is independent of Ras signaling. We further demonstrate that rare variants within the NF1-LRD domain found in a subset of the patients are pathogenic and reduce NF1-LRD’s invasion suppressive function. Taken together, our results show, for the first time, that NF1-LRD inhibits glioma invasion, and provides evidence of a previously unrecognized function of NF1-LRD in glioma biology.
Publisher
Nature Publishing Group UK,Nature Publishing Group
Subject
/ 13/1
/ 13/100
/ 13/106
/ 13/109
/ 13/44
/ 13/51
/ 13/95
/ 14/19
/ 14/63
/ 38
/ 38/22
/ 38/70
/ 38/89
/ 38/90
/ 42
/ 45/23
/ 45/29
/ 64/60
/ 82/80
/ Animals
/ Brain Neoplasms - metabolism
/ Glioma
/ Humans
/ Leucine
/ Medicine
/ Mice
/ Mutation
/ Neoplasm Invasiveness - genetics
/ Neurofibromin 1 - metabolism
/ Oncology
